NYSE$NEUE
NeueHealth Inc · Q4 2021 earnings
Q4 2021 earnings · · Investor relations
Briefing
Reported fourth quarter and full year 2021 financial results.
Bright Health Group reported a Q4 2021 revenue of $962.3 million, a 167.5% increase year-over-year. However, the company experienced a GAAP Net Loss of $813.4 million and an Adjusted EBITDA loss of $790.1 million.
- Achieved substantial growth in 2021, delivering $4 billion in Revenue.
- Reached a significant scale milestone of serving over 1 million health plan lives for the start of 2022.
- Experienced challenges during the year which resulted in worse than expected performance.
- Focused on driving results off our scaled platform in 2022 and beyond.
Headline financials
Revenue & EPS history
NeueHealth · Revenue · Quarterly
$962M
Forward guidance
For full year 2022, Bright Health Group expects a revenue of $6.8 to $7.1 billion and an adjusted EBITDA loss of $500 to $800 million.
Tailwinds
- Bright Health Group’s total Revenue is expected to be $6.8 billion to $7.1 billion
- Enterprise Medical Cost Ratio between 90% and 94%.
- Bright HealthCare end-of-year membership is expected to be approximately 1,000,000
- NeueHealth Revenue is expected to be approximately $2.3 billion.
- Intercompany Revenue elimination is expected to be approximately $1.2 to $1.4 billion.
Headwinds
- Adjusted EBITDA for 2022 is expected to be a loss of between $500.0 and $800.0 million
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q4 2021
-2.0%
Avg return
Earnings day
-6.9%
Avg return
5 days after
-17.7%
Avg return
30 days after
45%
10 / 22 earnings
Positive
+46.5%
Q1 2023
Best reaction
-43.1%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2025 | — | — | — | |
| Q2 2025 | +0.0% | -2.2% | -2.1% | |
| Q1 2025 | -2.2% | -0.4% | -1.5% | |
| Q4 2024 | +8.9% | +30.9% | +29.9% | |
| Q3 2024 | +2.2% | +2.5% | +7.8% | |
| Q2 2024 | -3.6% | +2.3% | -4.4% | |
| Q1 2024 | -4.0% | -3.7% | -14.3% | |
| Q4 2023 | +7.6% | -6.0% | -27.7% | |
| Q3 2023 | -1.5% | -10.2% | -15.5% | |
| Q2 2023 | -21.8% | -27.8% | -61.3% | |
| Q1 2023 | +46.5% | +7.2% | -14.1% | |
| Q4 2022 | -43.1% | -48.8% | -77.2% | |
| Q3 2022 | +4.3% | -3.7% | -15.3% | |
| Q2 2022 | -9.3% | +2.1% | -15.1% | |
| Q1 2022 | +35.7% | +26.0% | -0.6% | |
| Q4 2019 | -2.6% | -1.3% | -16.4% | |
| Q4 2021 | -29.5% | -42.9% | -35.6% | |
| Q3 2020 | +1.3% | -13.1% | -15.4% | |
| Q3 2021 | -35.1% | -34.4% | -40.5% | |
| Q2 2020 | +5.1% | — | — | |
| Q1 2021 | +5.1% | — | — | |
| Q4 2020 | +5.1% | — | — | |
| Q2 2021 | -13.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro